Manufacturers Life Cuts Investment in RadNet by 35%: Analyst Insights
The Manufacturers Life Insurance Company has strategically reduced its investment in RadNet, Inc. by 35% in the first quarter, as shown in a recent Securities and Exchange Commission filing. The company's current holding is 34,460 shares, down from 18,543 shares, with a valuation of approximately $1,926,000. This repositioning aligns with broader investment trends among institutional stakeholders.
Several significant stakeholders, including Quantinno Capital Management LP, which increased its RadNet investment by 23.4%, have altered their positions. Granahan Investment Management LLC acquired new shares worth $5,828,000, while Cetera Investment Advisers increased its holdings by 4.2%. PNC Financial Services Group Inc. and Van Berkom & Associates Inc. also bolstered their stakes, contributing to the 77.9% institutional and hedge fund ownership of RadNet's shares.
Analyst Perspectives and Ratings
Analysts present varying opinions on RadNet's market trajectory. Zacks Research downgraded the company to a "strong sell," whereas Jefferies Financial Group reaffirmed a "buy" rating. Weiss Ratings reduced its assessment from "sell (d)" to "sell (d-)." Barclays also adjusted its target price from $70 to $65, maintaining an "overweight" rating. Overall, these analyses resulted in a "Moderate Buy" consensus with an average price target of $87.43, according to MarketBeat.com.
Insider Trading Activities
Notable insider transactions include Director David L. Swartz selling 2,699 shares and CEO Cornelis Wesdorp divesting 4,750 shares. These sales reflect a decrease in their holdings by 1.50% and 6.43%, respectively. Currently, insiders hold approximately 5.14% of the company's shares.
RadNet's market metrics feature prominently, with NASDAQ RDNT opening at $72.39. The company’s financial indicators include a 50-day moving average of $60.95 and a 200-day moving average of $61.66, along with a debt-to-equity ratio of 0.79 and current and quick ratios of 1.17. RadNet's market capitalization is $5.69 billion, with a price-to-earnings ratio of -402.14 and a beta of 1.36.
In its quarterly earnings report on May 11th, RadNet revealed a 22.1% revenue increase year-over-year to $575.63 million, despite earnings per share not meeting predictions. Based in Los Angeles, RadNet specializes in outpatient diagnostic imaging services, operating a vast network of imaging centers across the U.S. For detailed analysis and disclosures, professionals in the industry may refer to platforms like HoldingsChannel.com.